Silence Therapeutics Operating Margin Growth & History (SLN)

Silence Therapeutics's operating margin was −16,292.84% for fiscal 2025.

View full Silence Therapeutics company overview

Silence Therapeutics annual operating margin history

Silence Therapeutics annual operating margin

Fiscal yearPeriod endedOperating marginChange (percentage points)
20252025-12-31−16,292.84%−16146.47 pp
20242024-12-31−146.38%+57.09 pp
20232023-12-31−203.47%+78.41 pp
20222022-12-31−281.87%

Silence Therapeutics operating margin trends

Between the periods ended 2022-12-31 and 2025-12-31, Silence Therapeutics's operating margin decreased from −281.87% to −16,292.84%, a change of −16010.97 percentage points. The latest reported quarter, Q1 2026, shows −3,729.15%.

About the metric

What operating margin means

Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.

Calculation and source

How operating margin is calculated

TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Silence Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about SLN yet. Start the conversation.

Write the first post